SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CNSI Cambridge Neuroscience
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TheSlowLane who wrote (166)5/22/1997 9:11:00 PM
From: NeuroInvestment   of 675
 
The neuro sector has recovered somewhat over the past month, but is simply not as oversold as it was. I would not call it a rally at this point. The recent rises in CNSI and NTII have their own specific precipitants: 1) As noted by the previous post, the new CEO of NTII, who used to run Syntex, is seen as a positive move because he is well connected with Big Pharma, and NTII very much needs to seal its first corporate alliance. 2) CNSI is responding to what I suspect is some people positioning themselves for interim Cerestat data during the
summer. I doubt that continued GGF speculation, or the fact that CNS5161 will go into Phase I by the end of June, would account for the rise. One other note: a recent post stated that NTII and CNSI are not competitors. That is not actually the case: Both have an NMDA antagonist as a lead compound (NTII with memantine, CNSI with Cerestat). NTII indeed went into AIDS dementia with memantine because Cerestat has such a lead in stroke/TBI, AIDS dementia was wide open, and they hope for expedited approval. In the future they still hope to forward memantine for stroke/TBI also. NTII has also started neuropathic pain trials for memantine, and CNSI plans to take its second generation NMDA blocker CNS5161 into neuropathic pain trials (as well as CABG surgery). Thus they do have competitive programs. NeuroInvestment
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News